| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $198.8M | +3.2% |
| R&D Expense | $74.4M | -3.1% |
| SG&A Expense | $146.4M | +29.7% |
| Operating Income | -$40.7M | -191.4% |
| Pre-tax Income | -$22.9M | -461.6% |
| Income Tax | -$4.0M | -205.0% |
| Net Income | -$18.9M | -853.3% |
| EPS (Basic) | -$0.33 | -925.0% |
| EPS (Diluted) | -$0.33 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $102.3M | -24.7% |
| Accounts Receivable | $47.1M | +37.9% |
| Inventory | $1.7M | +27.2% |
| Current Assets | $438.9M | +1.4% |
| Total Assets | $656.2M | +1.2% |
| Current Liabilities | $100.0M | +14.0% |
| Total Liabilities | $117.7M | +13.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.8M | -223.1% |
| Capital Expenditures | $490K | +27.9% |
| Investing Cash Flow | -$17.4M | -44.6% |
| Financing Cash Flow | -$155K | — |
| Free Cash Flow | -$16.2M | -230.8% |
| -925.0% |
| Stockholders' Equity |
| $538.5M |
| -1.2% |